<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>MY WAYÂ - levonorgestrelÂ tabletÂ </strong><br>GAVIS Pharmaceuticals, LLC.<br></p></div>
<div id="Highlights" class="Highlights"><table cellspacing="5" cellpadding="5" width="100%" style="table-layout:fixed"><tr><td align="left" valign="top"><div>
<h1>HIGHLIGHTS OF PRESCRIBING INFORMATION</h1>
<div class="HighlightsDisclaimer">
<br>These highlights do not include all the information needed to use My Way safely and effectively. See full prescribing information for My Way.<br><br>My Way (Levonorgestrel) TABLET for ORAL use.<br>Initial U.S. Approval: 1982</div>
<div></div>
<div class="HighlightSection">
<h1 class="Highlights"><span>INDICATIONS AND USAGE</span></h1>
<div><p class="Highlighta"> My way is a progestin-only emergency contraceptive indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure. My way is available only by prescription for women younger than age 17 years, and available over the counter for women 17 years and older. My way is not intended for routine use as a contraceptive. (<a href="#b23d1be8-359b-4d99-8bb9-d38c5b196275">1</a>) </p></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DOSAGE AND ADMINISTRATION</span></h1>
<div><p class="Highlighta"> One tablet taken orally <span class="Underline">as soon as possible within 72 hours</span> after unprotected intercourse. Efficacy is better if the tablet is taken as soon as possible after unprotected intercourse. (<a href="#bf7f14d6-91c6-4bab-9540-1f807cecb0d4">2</a>) </p></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DOSAGE FORMS AND STRENGTHS</span></h1>
<div><p class="Highlighta"> 1.5 mg tablet (<a href="#b9105f13-6dbd-4ebf-8fc9-1331d6ad8e6f">3</a>) </p></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>CONTRAINDICATIONS</span></h1>
<div><p class="Highlighta"> Known or suspected pregnancy (<a href="#b94a0fd8-3bb5-42d1-a77c-88c3b73c7903">4</a>) </p></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>WARNINGS AND PRECAUTIONS</span></h1>
<div><ul>
<li> <span class="product-label-link" type="condition" conceptid="437611" conceptname="Ectopic pregnancy">Ectopic pregnancy</span>: Women who become pregnant or complain of <span class="product-label-link" type="condition" conceptid="193322" conceptname="Right lower quadrant pain">lower abdominal pain</span> after taking My way should be evaluated for <span class="product-label-link" type="condition" conceptid="437611" conceptname="Ectopic pregnancy">ectopic pregnancy</span>. (<a href="#b7469205-7a11-4063-9660-4ac69d9f141b">5.1</a>)</li>
<li> My way is not effective in terminating an existing pregnancy. (<a href="#b3005f62-f99d-4a9f-8f74-f980da63e21e">5.2</a>)</li>
<li> Effect on menses: My way may alter the next expected menses. If menses is delayed beyond 1 week, pregnancy should be considered. (<a href="#bb4b3fca-fea9-4539-967d-c6c2ce4919d9">5.3</a>)</li>
<li> STI/HIV: My way does not protect against STI/HIV. (<a href="#bd014d60-c46d-46f5-adfb-f9479cabcaa7">5.4</a>)</li>
</ul></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>ADVERSE REACTIONS</span></h1>
<div>
<p class="Highlighta"> The most common adverse reactions (â‰¥10%) in clinical trials included heavier menstrual <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> (31%), <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> (14%), <span class="product-label-link" type="condition" conceptid="193322" conceptname="Right lower quadrant pain">lower abdominal pain</span> (13%), <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span> (13%), <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> (10%), and <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span> (10%). (<a href="#b538163a-84c6-4e5c-9c1f-8790afbce248">6.1</a>) </p>
<p class="Highlighta"><span class="Bold">To report SUSPECTED ADVERSE REACTIONS, contactÂ  atÂ  or FDA at 1-800-FDA-1088 or <span class="Bold Italics">www.fda.gov/medwatch.</span></span> </p>
</div>
<div></div>
<div></div>
</div>
<div></div>
<div class="HighlightSection">
<h1 class="Highlights"><span>USE IN SPECIFIC POPULATIONS</span></h1>
<div><ul>
<li> Nursing Mothers: Small amounts of progestin pass into the breast milk of nursing women taking progestin-only pills for long-term contraception, resulting in detectable steroid levels in infant plasma. (<a href="#bef7dad0-8c27-4da2-be07-0a290d0a8e9e">8.3</a>)</li>
<li> My wayÂ  is not intended for use in premenarcheal (<a href="#bc28c378-685c-4f03-8efd-e96ae79e65c2">8.4</a>) or postmenopausal females (<a href="#b9e9e02c-ea88-43f1-ae3f-60bbafe6c987">8.5</a>).</li>
</ul></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
</div>
<div></div>
<div></div>
<div></div>
<div>
<div></div>
<div></div>
</div>
<div><div></div></div>
<div></div>
<div></div>
<div><div></div></div>
<div></div>
<p class="HighlightsSeeReference">See 17 for PATIENT COUNSELING INFORMATION.</p>
<p class="HighlightsRevision">Revised: 2/2013</p>
</div></td></tr></table></div>
<div id="Index" class="Index"><table cellspacing="5" cellpadding="5" width="100%" style="table-layout:fixed"><tr><td align="left" valign="top"><div>
<h1 class="Colspan">FULL PRESCRIBING INFORMATION: CONTENTS<a href="#footnote-content" name="footnote-reference-content">*</a>
</h1>
<h1><a href="#section-1" class="toc"><span class="Bold">1Â  INDICATIONS AND USAGE
</span></a></h1>
<h1><a href="#section-2" class="toc"><span class="Bold">2Â  DOSAGE AND ADMINISTRATION
</span></a></h1>
<h1><a href="#section-3" class="toc"><span class="Bold">3Â  DOSAGE FORMS AND STRENGTHS
</span></a></h1>
<h1><a href="#section-4" class="toc"><span class="Bold">4Â  CONTRAINDICATIONS
</span></a></h1>
<h1><a href="#section-5" class="toc"><span class="Bold">5Â  WARNINGS AND PRECAUTIONS
</span></a></h1>
<h2><a href="#section-5.1" class="toc"><span class="Bold">5.1 <span class="product-label-link" type="condition" conceptid="437611" conceptname="Ectopic pregnancy">Ectopic Pregnancy</span> 
</span></a></h2>
<h2><a href="#section-5.2" class="toc"><span class="Bold">5.2 Existing Pregnancy 
</span></a></h2>
<h2><a href="#section-5.3" class="toc"><span class="Bold">5.3 Effects on Menses 
</span></a></h2>
<h2><a href="#section-5.4" class="toc"><span class="Bold">5.4 STI/HIV 
</span></a></h2>
<h2><a href="#section-5.5" class="toc"><span class="Bold">5.5 Physical Examination and Follow-up 
</span></a></h2>
<h2><a href="#section-5.6" class="toc"><span class="Bold">5.6 Fertility Following Discontinuation 
</span></a></h2>
<h1><a href="#section-6" class="toc"><span class="Bold">6Â  ADVERSE REACTIONS
</span></a></h1>
<h2><a href="#section-6.1" class="toc"><span class="Bold">6.1 Clinical Trials Experience 
</span></a></h2>
<h2><a href="#section-6.2" class="toc"><span class="Bold">6.2 Postmarketing Experience 
</span></a></h2>
<h1><a href="#section-7" class="toc"><span class="Bold">7Â  DRUG INTERACTIONS
</span></a></h1>
<h1><a href="#section-8" class="toc"><span class="Bold">8Â  USE IN SPECIFIC POPULATIONS
</span></a></h1>
<h2><a href="#section-8.1" class="toc"><span class="Bold">8.1Â  Pregnancy 
</span></a></h2>
<h2><a href="#section-8.2" class="toc"><span class="Bold">8.3 Nursing Mothers 
</span></a></h2>
<h2><a href="#section-8.3" class="toc"><span class="Bold">8.4 Pediatric Use
</span></a></h2>
<h2><a href="#section-8.4" class="toc"><span class="Bold">8.5 Geriatric Use
</span></a></h2>
<h2><a href="#section-8.5" class="toc"><span class="Bold">8.6 Race 
</span></a></h2>
<h2><a href="#section-8.6" class="toc"><span class="Bold">8.7 <span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">Hepatic Impairment</span> 
</span></a></h2>
<h2><a href="#section-8.7" class="toc"><span class="Bold">8.8 <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">Renal Impairment</span> 
</span></a></h2>
<h1><a href="#section-9" class="toc"><span class="Bold">9Â  DRUG ABUSE AND <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">DEPENDENCE</span>
</span></a></h1>
<h1><a href="#section-10" class="toc"><span class="Bold">10Â  OVERDOSAGE
</span></a></h1>
<h1><a href="#section-11" class="toc"><span class="Bold">11Â  DESCRIPTION
</span></a></h1>
<h1><a href="#section-12" class="toc"><span class="Bold">12Â  CLINICAL PHARMACOLOGY
</span></a></h1>
<h2><a href="#section-12.1" class="toc"><span class="Bold Italics">12.1 Mechanism of Action
</span></a></h2>
<h2><a href="#section-12.2" class="toc"><span class="Bold Italics">12.3 Pharmacokinetics
</span></a></h2>
<h1><a href="#section-13" class="toc"><span class="Bold">13Â  NONCLINICAL TOXICOLOGY
</span></a></h1>
<h2><a href="#section-13.1" class="toc"><span class="Bold">13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility 
</span></a></h2>
<h1><a href="#section-14" class="toc"><span class="Bold">14Â  CLINICAL STUDIES
</span></a></h1>
<h1><a href="#section-15" class="toc"><span class="Bold">16Â  HOW SUPPLIED/STORAGE AND HANDLING
</span></a></h1>
<h1><a href="#section-16" class="toc"><span class="Bold">17 PATIENT COUNSELING INFORMATION
</span></a></h1>
<h2><a href="#section-16.1" class="toc"><span class="Bold">17.1 Information for Patients 
</span></a></h2>
<dl class="Footnote">
<dt><a href="#footnote-reference-content" name="footnote-content">*</a></dt>
<dd>Sections or subsections omitted from the full prescribing information are not listed.</dd>
</dl>
</div></td></tr></table></div>
<div class="Contents">
<h1>FULL PRESCRIBING INFORMATION</h1>
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="b23d1be8-359b-4d99-8bb9-d38c5b196275"></a><a name="section-1"></a><p></p>
<h1><span class="Bold">1Â  INDICATIONS AND USAGE
</span></h1>
<p class="First"></p>
<p>My Way is a progestin-only emergency contraceptive indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure. To obtain optimal efficacy, the tablet should be taken as soon as possible within 72 hours of intercourse.</p>
<p>My Way is available only by prescription for women younger than age 17 years, and available over the counter for women 17 years and older. My Way is not indicated for routine use as a contraceptive.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="bf7f14d6-91c6-4bab-9540-1f807cecb0d4"></a><a name="section-2"></a><p></p>
<h1><span class="Bold">2Â  DOSAGE AND ADMINISTRATION
</span></h1>
<p class="First"></p>
<p>Take My Way orally <span class="Underline">as soon as possible within 72 hours</span> after unprotected intercourse or a known or suspected contraceptive failure. Efficacy is better if the tablet is taken as soon as possible after unprotected intercourse. My Way can be used at any time during the menstrual cycle.</p>
<p>If <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> occurs within two hours of taking the tablet, consideration should be given to repeating the dose.</p>
</div>
<div class="Section" data-sectionCode="43678-2">
<a name="b9105f13-6dbd-4ebf-8fc9-1331d6ad8e6f"></a><a name="section-3"></a><p></p>
<h1><span class="Bold">3Â  DOSAGE FORMS AND STRENGTHS
</span></h1>
<p class="First"></p>
<p>The My Way tablet is supplied as a white to off-white, round, flat tablets containing 1.5 mg of levonorgestrel and debossed with â€œNL 620â€? on one side and plain on the other side.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="b94a0fd8-3bb5-42d1-a77c-88c3b73c7903"></a><a name="section-4"></a><p></p>
<h1><span class="Bold">4Â  CONTRAINDICATIONS
</span></h1>
<p class="First"></p>
<p>My Way is contraindicated for use in the case of known or suspected pregnancy.</p>
</div>
<div class="Section" data-sectionCode="43685-7">
<a name="section-5"></a><p></p>
<h1><span class="Bold">5Â  WARNINGS AND PRECAUTIONS
</span></h1>
<div class="Section">
<a name="b7469205-7a11-4063-9660-4ac69d9f141b"></a><a name="section-5.1"></a><p></p>
<h2><span class="Bold">5.1 <span class="product-label-link" type="condition" conceptid="437611" conceptname="Ectopic pregnancy">Ectopic Pregnancy</span> 
</span></h2>
<p class="First">Ectopic pregnancies account for approximately 2% of all reported pregnancies. Up to 10% of pregnancies reported in clinical studies of routine use of progestin-only contraceptives are ectopic.</p>
<p>A history of <span class="product-label-link" type="condition" conceptid="437611" conceptname="Ectopic pregnancy">ectopic pregnancy</span> is not a contraindication to use of this emergency contraceptive method. Healthcare providers, however, should consider the possibility of an <span class="product-label-link" type="condition" conceptid="437611" conceptname="Ectopic pregnancy">ectopic pregnancy</span> in women who become pregnant or complain of <span class="product-label-link" type="condition" conceptid="193322" conceptname="Right lower quadrant pain">lower abdominal pain</span> after taking My Way. A follow-up physical or pelvic examination is recommended if there is any doubt concerning the general health or pregnancy status of any woman after taking My Way.</p>
</div>
<div class="Section">
<a name="b3005f62-f99d-4a9f-8f74-f980da63e21e"></a><a name="section-5.2"></a><p></p>
<h2><span class="Bold">5.2 Existing Pregnancy 
</span></h2>
<p class="First">My Way is not effective in terminating an existing pregnancy.</p>
</div>
<div class="Section">
<a name="bb4b3fca-fea9-4539-967d-c6c2ce4919d9"></a><a name="section-5.3"></a><p></p>
<h2><span class="Bold">5.3 Effects on Menses 
</span></h2>
<p class="First">Some women may experience spotting a few days after taking My Way. Menstrual <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> patterns are often irregular among women using progestin-only oral contraceptives and women using levonorgestrel for postcoital and emergency contraception.</p>
<p>If there is a delay in the onset of expected menses beyond 1 week, consider the possibility of pregnancy.</p>
</div>
<div class="Section">
<a name="bd014d60-c46d-46f5-adfb-f9479cabcaa7"></a><a name="section-5.4"></a><p></p>
<h2><span class="Bold">5.4 STI/HIV 
</span></h2>
<p class="First">My Way does not protect against <span class="product-label-link" type="condition" conceptid="439727" conceptname="Human immunodeficiency virus infection">HIV infection</span> (AIDS) or other sexually transmitted <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> (STIs).</p>
</div>
<div class="Section">
<a name="section-5.5"></a><p></p>
<h2><span class="Bold">5.5 Physical Examination and Follow-up 
</span></h2>
<p class="First">A physical examination is not required prior to prescribing My Way. A follow-up physical or pelvic examination is recommended if there is any doubt concerning the general health or pregnancy status of any woman after taking My Way.</p>
</div>
<div class="Section">
<a name="section-5.6"></a><p></p>
<h2><span class="Bold">5.6 Fertility Following Discontinuation 
</span></h2>
<p class="First">A rapid return of fertility is likely following treatment with My Way for emergency contraception; therefore, routine contraception should be continued or initiated as soon as possible following use of My Way to ensure ongoing prevention of pregnancy.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-6"></a><p></p>
<h1><span class="Bold">6Â  ADVERSE REACTIONS
</span></h1>
<p class="First"></p>
<div class="Section">
<a name="b538163a-84c6-4e5c-9c1f-8790afbce248"></a><a name="section-6.1"></a><p></p>
<h2><span class="Bold">6.1 Clinical Trials Experience 
</span></h2>
<p class="First">Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.</p>
<p>My Way was studied in a randomized, double-blinded multicenter clinical trial. In this study, all women who had received at least one dose of study medication were included in the safety analysis: 1,379 women in the My Way group, and 1,377 women in the Plan B group (2 doses of 0.75 mg levonorgestrel taken 12 hours apart). The mean age of women given My Way was 27 years. The racial demographic of those enrolled was 54% Chinese, 12% Other Asian or Black, and 34% were Caucasian in each treatment group. 1.6% of women in the My Way group and 1.4% in Plan B group were lost to follow-up.</p>
<p>The most common adverse events (&gt;10%) in the clinical trial for women receiving My Way included heavier menstrual <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> (30.9%), <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> (13.7%), <span class="product-label-link" type="condition" conceptid="193322" conceptname="Right lower quadrant pain">lower abdominal pain</span> (13.3%), <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span> (13.3%), and <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> (10.3%). Table 1 lists those adverse events that were reported in &gt; 4% of My Way users.</p>
<table frame="void" width="590">
<caption><span> Table 1. Adverse Events in &gt; 4% of Women, by % Frequency</span></caption>
<thead><tr class="First Last">
<td class="BotruleLruleRruleToprule" align="left" valign="top"><span class="Bold">Most Common Adverse Events (MedDRA)</span></td>
<td class="BotruleLruleRruleToprule" align="left" valign="top"></td>
</tr></thead>
<tbody>
<tr class="First">
<td class="BotruleLruleRruleToprule" align="left" valign="top">Heavier menstrual <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span></td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">30.9</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span></td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">13.7</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="193322" conceptname="Right lower quadrant pain">Lower abdominal pain</span></td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">13.3</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">Fatigue</span></td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">13.3</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span></td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">10.3</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span></td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">9.6</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4208409" conceptname="Breast tenderness">Breast tenderness</span></td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">8.2</td>
</tr>
<tr class="Last">
<td class="BotruleLruleRruleToprule" align="left" valign="top">Delay of menses (&gt; 7 days)</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">4.5</td>
</tr>
</tbody>
</table>
</div>
<div class="Section">
<a name="section-6.2"></a><p></p>
<h2><span class="Bold">6.2 Postmarketing Experience 
</span></h2>
<p class="First">The following adverse reactions have been identified during post-approval use of Plan B (2 doses of 0.75 mg levonorgestrel taken 12 hours apart). Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.</p>
<p><span class="Italics"><span class="product-label-link" type="condition" conceptid="4302537" conceptname="Digestive system finding">Gastrointestinal Disorders</span> </span></p>
<p><span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal Pain</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Vomiting</span></p>
<p><span class="Italics">General Disorders and Administration Site Conditions </span></p>
<p><span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">Fatigue</span></p>
<p><span class="Italics"><span class="product-label-link" type="condition" conceptid="376337" conceptname="Disorder of nervous system">Nervous System Disorders</span> </span></p>
<p><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span></p>
<p><span class="Italics">Reproductive System and <span class="product-label-link" type="condition" conceptid="77030" conceptname="Disorder of breast">Breast Disorders</span> </span></p>
<p><span class="product-label-link" type="condition" conceptid="194696" conceptname="Dysmenorrhea">Dysmenorrhea</span>, <span class="product-label-link" type="condition" conceptid="196168" conceptname="Irregular periods">Irregular Menstruation</span>, <span class="product-label-link" type="condition" conceptid="442274" conceptname="Oligomenorrhea">Oligomenorrhea</span>, <span class="product-label-link" type="condition" conceptid="4147829" conceptname="Pain in pelvis">Pelvic Pain</span></p>
</div>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="be0df4b7-a16f-4d5a-b52d-32fcaaa486e9"></a><a name="section-7"></a><p></p>
<h1><span class="Bold">7Â  DRUG INTERACTIONS
</span></h1>
<p class="First">Drugs or herbal products that induce certain enzymes, such as CYP3A4, may decrease the effectiveness of progestin-only pills. (7)</p>
<p>Drugs or herbal products that induce enzymes, including CYP3A4, that metabolize progestins may decrease the plasma concentrations of progestins, and may decrease the effectiveness of progestin-only pills. Some drugs or herbal products that may decrease the effectiveness of progestin-only pills include:</p>
<ul class="Disc">
<li>barbiturates</li>
<li>bosentan</li>
<li>carbamazepine</li>
<li>felbamate</li>
<li>griseofulvin</li>
<li>oxcarbazepine</li>
<li>phenytoin</li>
<li>rifampin</li>
<li>St. Johnâ€™s wort</li>
<li>topiramate</li>
</ul>
<p>Significant changes (increase or decrease) in the plasma levels of the progestin have been noted in some cases of co-administration with HIV protease inhibitors or with non-nucleoside reverse transcriptase inhibitors.</p>
<p>Consult the labeling of all concurrently used drugs to obtain further information about interactions with progestin-only pills or the potential for enzyme alterations.</p>
</div>
<div class="Section" data-sectionCode="43684-0">
<a name="section-8"></a><p></p>
<h1><span class="Bold">8Â  USE IN SPECIFIC POPULATIONS
</span></h1>
<div class="Section" data-sectionCode="42228-7">
<a name="section-8.1"></a><p></p>
<h2><span class="Bold">8.1Â  Pregnancy 
</span></h2>
<p class="First">Many studies have found no harmful effects on fetal development associated with long-term use of contraceptive doses of oral progestins. The few studies of infant growth and development that have been conducted with progestin-only pills have not demonstrated significant adverse effects.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="bef7dad0-8c27-4da2-be07-0a290d0a8e9e"></a><a name="section-8.2"></a><p></p>
<h2><span class="Bold">8.3 Nursing Mothers 
</span></h2>
<p class="First">In general, no adverse effects of progestin-only pills have been found on breastfeeding performance or on the health, growth, or development of the infant. However, isolated post-marketing cases of decreased milk production have been reported. Small amounts of progestins pass into the breast milk of nursing mothers taking progestin-only pills for long-term contraception, resulting in detectable steroid levels in infant plasma.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="bc28c378-685c-4f03-8efd-e96ae79e65c2"></a><a name="section-8.3"></a><p></p>
<h2><span class="Bold">8.4 Pediatric Use
</span></h2>
<p class="First">Safety and efficacy of progestin-only pills for long-term contraception have been established in women of reproductive age. Safety and efficacy are expected to be the same for postpubertal adolescents less than 17 years and for users 17 years and older. Use of My Way emergency contraception before <span class="product-label-link" type="condition" conceptid="4061459" conceptname="Menarche">menarche</span> is not indicated.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="b9e9e02c-ea88-43f1-ae3f-60bbafe6c987"></a><a name="section-8.4"></a><p></p>
<h2><span class="Bold">8.5 Geriatric Use
</span></h2>
<p class="First">This product is not intended for use in postmenopausal women.</p>
</div>
<div class="Section">
<a name="b5cc8e49-2444-418d-a94d-a6541829d410"></a><a name="section-8.5"></a><p></p>
<h2><span class="Bold">8.6 Race 
</span></h2>
<p class="First">No formal studies have evaluated the effect of race. However, clinical trials demonstrated a higher pregnancy rate in Chinese women with both Plan B and the Yuzpe regimen (another form of emergency contraception). There was a non-statistically significant increased rate of pregnancy among Chinese women in the My Way trial. The reason for this apparent increase in the pregnancy rate with emergency contraceptives in Chinese women is unknown.</p>
</div>
<div class="Section">
<a name="section-8.6"></a><p></p>
<h2><span class="Bold">8.7 <span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">Hepatic Impairment</span> 
</span></h2>
<p class="First">No formal studies were conducted to evaluate the effect of <span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">hepatic disease</span> on the disposition of levonorgestrel tablet.</p>
</div>
<div class="Section">
<a name="section-8.7"></a><p></p>
<h2><span class="Bold">8.8 <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">Renal Impairment</span> 
</span></h2>
<p class="First">No formal studies were conducted to evaluate the effect of <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span> on the disposition of My Way.</p>
</div>
</div>
<div class="Section" data-sectionCode="42227-9">
<a name="section-9"></a><p></p>
<h1><span class="Bold">9Â  DRUG ABUSE AND <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">DEPENDENCE</span>
</span></h1>
<p class="First">Levonorgestrel is not a controlled substance. There is no information about <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">dependence</span> associated with the use of My Way.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-10"></a><p></p>
<h1><span class="Bold">10Â  OVERDOSAGE
</span></h1>
<p class="First">There are no data on overdosage of My Way, although the common adverse event of <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> and associated <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> may be anticipated.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-11"></a><p></p>
<h1><span class="Bold">11Â  DESCRIPTION
</span></h1>
<p class="First">The My Way Tablet contains 1.5 mg of a single active steroid ingredient, levonorgestrel [18,19-Dinorpregn-4-en-20-yn-3-one-13-ethyl-17-hydroxy-, (17Î±)-(-)-], a totally synthetic progestogen. The inactive ingredients are colloidal silicon dioxide, pregelatinized starch, lactose monohydrate, magnesium stearate, and talc.</p>
<p>Levonorgestrel has a molecular weight of 312.45, and the following structural and molecular formulas:</p>
<div class="Figure"><img alt="07b96626-figure-01" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c749c15a-2c92-4db9-a6b9-fdf18da5b7da&amp;name=07b96626-figure-01.jpg"></div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-12"></a><p></p>
<h1><span class="Bold">12Â  CLINICAL PHARMACOLOGY
</span></h1>
<div class="Section" data-sectionCode="43679-0">
<a name="section-12.1"></a><p></p>
<h2><span class="Bold Italics">12.1 Mechanism of Action
</span></h2>
<p class="First">Emergency contraceptive pills are not effective if a woman is already pregnant. My Way is believed to act as an emergency contraceptive principally by preventing ovulation or fertilization (by altering tubal transport of sperm and/or ova). In addition, it may inhibit implantation (by altering the endometrium). It is not effective once the process of implantation has begun.</p>
</div>
<div class="Section" data-sectionCode="43682-4">
<a name="section-12.2"></a><p></p>
<h2><span class="Bold Italics">12.3 Pharmacokinetics
</span></h2>
<p class="First"><span class="Italics">Absorption </span></p>
<p>Following a single dose administration of My Way in 30 women under fasting conditions, maximum plasma concentrations of levonorgestrel of 19.1 ng/mL were reached at 1.7 hours. See Table 2.</p>
<p>of My Way (levonorgestrel) tablet 1.5 mg to 30 Healthy Female Volunteers under Fasting Conditions[/TC]</p>
<table frame="void" width="661">
<thead>
<tr class="First"><td class="BotruleLruleRruleToprule" align="left" colspan="6" valign="top"> Mean (Â± SD)</td></tr>
<tr class="Last">
<td class="BotruleLruleRruleToprule" align="left" valign="top"></td>
<td class="BotruleLruleRruleToprule" align="left" valign="top"> C<span class="Sub">max</span>(ng/mL)</td>
<td class="BotruleLruleRruleToprule" align="left" valign="top"> AUC<span class="Sub">t</span>(ngÂ·hr/mL)*</td>
<td class="BotruleLruleRruleToprule" align="left" valign="top"> AUC<span class="Sub">inf</span>(ngÂ·hr/mL)*</td>
<td class="BotruleLruleRruleToprule" align="left" valign="top"> T<span class="Sub">max</span>(hr)**</td>
<td class="BotruleLruleRruleToprule" align="left" valign="top"> t<span class="Sub">1/2 </span>(hr)</td>
</tr>
</thead>
<tbody><tr class="First Last">
<td class="BotruleLruleRruleToprule" align="left" valign="top">Levonorgestrel</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">19.1 ( 9.7)</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">294.8(208.8)</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">307.5(218.5)</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">1.7(1.0-4.0)</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">27.5(5.6)</td>
</tr></tbody>
</table>
<p>C<span class="Sub">max</span> = maximum concentration</p>
<p>AUC<span class="Sub">t</span> = area under the drug concentration curve from time 0 to time of last determinable concentration</p>
<p>AUC<span class="Sub">inf</span> = area under the drug concentration curve from time 0 to infinity</p>
<p>T<span class="Sub">max</span> = time to maximum concentration</p>
<p>t<span class="Sub">1/2 </span>= elimination half life</p>
<p>* N=29</p>
<p>** median (range)</p>
<p>Effect of Food: The effect of food on the rate and the extent of levonorgestrel absorption following single oral administration of My Way has not been evaluated.</p>
<p><span class="Italics">Distribution </span></p>
<p>The apparent volume of distribution of levonorgestrel is reported to be approximately 1.8 L/kg. It is about 97.5 to 99% protein-bound, principally to <span class="product-label-link" type="condition" conceptid="4206320" conceptname="Sex steroid binding globulin">sex hormone binding globulin</span> (SHBG) and, to a lesser extent, serum albumin.</p>
<p><span class="Italics">Metabolism </span></p>
<p>Following absorption, levonorgestrel is conjugated at the 17Î²-OH position to form sulfate conjugates and, to a lesser extent, glucuronide conjugates in plasma. Significant amounts of conjugated and unconjugated 3Î±, 5Î²-tetrahydrolevonorgestrel are also present in plasma, along with much smaller amounts of 3Î±, 5Î±-tetrahydrolevonorgestrel and 16Î²-hydroxylevonorgestrel. Levonorgestrel and its phase I metabolites are excreted primarily as glucuronide conjugates. Metabolic clearance rates may differ among individuals by several-fold, and this may account in part for the wide variation observed in levonorgestrel concentrations among users.</p>
<p><span class="Italics">Excretion </span></p>
<p>About 45% of levonorgestrel and its metabolites are excreted in the urine and about 32% are excreted in feces, mostly as glucuronide conjugates.</p>
<p><span class="Bold">Specific Populations </span></p>
<p><span class="Italics">Pediatric </span></p>
<p>This product is not intended for use in the premenarcheal population, and pharmacokinetic data are not available for this population.</p>
<p><span class="Italics">Geriatric </span></p>
<p>This product is not intended for use in postmenopausal women, and pharmacokinetic data are not available for this population.</p>
<p><span class="Italics">Race </span></p>
<p>No formal studies have evaluated the effect of race. However, clinical trials demonstrated a higher pregnancy rate in Chinese women with both Plan B and the Yuzpe regimen (another form of emergency contraception). There was a non-statistically significant increased rate of pregnancy among Chinese women in the My Way trial. The reason for this apparent increase in the pregnancy rate with emergency contraceptives in Chinese women is unknown [see <a href="#b5cc8e49-2444-418d-a94d-a6541829d410">USE IN SPECIFIC POPULATIONS (8.6)</a>].</p>
<p><span class="Italics"><span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">Hepatic Impairment</span> </span></p>
<p>No formal studies were conducted to evaluate the effect of <span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">hepatic disease</span> on the disposition of My Way.</p>
<p><span class="Italics"><span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">Renal Impairment</span> </span></p>
<p>No formal studies were conducted to evaluate the effect of <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span> on the disposition of My Way.</p>
<p><span class="Bold">Drug-Drug Interactions </span></p>
<p>No formal drug-drug interaction studies were conducted with My Way [see <a href="#be0df4b7-a16f-4d5a-b52d-32fcaaa486e9">DRUG INTERACTIONS (7)</a>].</p>
</div>
</div>
<div class="Section" data-sectionCode="43680-8">
<a name="section-13"></a><p></p>
<h1><span class="Bold">13Â  NONCLINICAL TOXICOLOGY
</span></h1>
<div class="Section" data-sectionCode="34083-6">
<a name="section-13.1"></a><p></p>
<h2><span class="Bold">13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility 
</span></h2>
<p class="First">Carcinogenicity: There is no evidence of increased risk of cancer with short-term use of progestins. There was no increase in tumorgenicity following administration of levonorgestrel to rats for 2 years at approximately 5 Âµg/day, to dogs for 7 years at up to 0.125 mg/kg/day, or to rhesus monkeys for 10 years at up to 250 Âµg/kg/day. In another 7 year dog study, administration of levonorgestrel at 0.5 mg/kg/day did increase the number of mammary <span class="product-label-link" type="condition" conceptid="4106411" conceptname="Adenofibroma">adenomas</span> in treated dogs compared to controls. There were no malignancies.</p>
<p>Genotoxicity: Levonorgestrel was not found to be mutagenic or genotoxic in the Ames Assay, in vitro mammalian culture assays utilizing mouse <span class="product-label-link" type="condition" conceptid="432571" conceptname="Malignant lymphoma">lymphoma</span> cells and Chinese hamster ovary cells, and in an in vivo micronucleus assay in mice.</p>
<p>Fertility: There are no irreversible effects on fertility following cessation of exposures to levonorgestrel or progestins in general.</p>
</div>
</div>
<div class="Section" data-sectionCode="34092-7">
<a name="section-14"></a><p></p>
<h1><span class="Bold">14Â  CLINICAL STUDIES
</span></h1>
<p class="First">A double-blind, randomized, multicenter, multinational study evaluated and compared the efficacy and safety of three different regimens for emergency contraception. Subjects were enrolled at 15 sites in 10 countries; the racial/ethnic characteristics of the study population overall were 54% Chinese, 34% Caucasian, and 12% Black or Asian (other than Chinese). 2,381 healthy women with a mean age of 27 years, who needed emergency contraception within 72 hours of unprotected intercourse were involved and randomly allocated into one of the two levonorgestrel groups. A single dose of 1.5 mg of levonorgestrel (My Way) was administered to women allocated into group 1. Two doses of 0.75 mg levonorgestrel 12 hours apart (Plan B) were administered to women in group 2. In the My Way group, 16 pregnancies occurred in 1,198 women and in the Plan B group, 20 pregnancies occurred in 1,183 women. The number of pregnancies expected in each group was calculated based on the timing of intercourse with regard to each womanâ€™s menstrual cycle. Among women receiving My Way, 84% of expected pregnancies were prevented and among those women taking Plan B, 79% of expected pregnancies were prevented. The expected pregnancy rate of 8% (with no contraceptive use) was reduced to approximately 1% with My Way.</p>
<p>Emergency contraceptives are not as effective as routine contraception since their failure rate, while low based on a single use, would accumulate over time with repeated use [see <a href="#b23d1be8-359b-4d99-8bb9-d38c5b196275">INDICATIONS AND USAGE (1)</a>].</p>
<p>In the clinical study, <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> disturbances were the most common adverse event reported after taking the levonorgestrel-containing regimens. More than half of the women had menses within two days of the expected time; however, 31% of women experienced change in their <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> pattern during the study period; 4.5% of women had menses more than 7 days after the expected time.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-15"></a><p></p>
<h1><span class="Bold">16Â  HOW SUPPLIED/STORAGE AND HANDLING
</span></h1>
<p class="First">The My Way (Levonorgestrel) tablet , 1.5 mg is available in a PVC/aluminum foil <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">blister</span> package. The tablet is a white to off-white, round, flat tablet debossed with â€œNL 620â€? on one side and plain on the other side containing 1.5 mg of levonorgestrel.</p>
<p>NDC 43386-620-30 (1 tablet unit of use package)</p>
<p>Store My Way at 20Â° to 25Â°C (68Â° to 77Â°F) [see USP Controlled Room Temperature].</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-16"></a><p></p>
<h1><span class="Bold">17 PATIENT COUNSELING INFORMATION
</span></h1>
<div class="Section">
<a name="section-16.1"></a><p></p>
<h2><span class="Bold">17.1 Information for Patients 
</span></h2>
<ul class="Disc">
<li>Take My Way as soon as possible and not more than 72 hours after unprotected intercourse or a known or suspected contraceptive failure.</li>
<li>If you vomit within two hours of taking the tablet, immediately contact your healthcare provider to discuss whether to take another tablet.</li>
<li>Seek medical attention if you experience severe <span class="product-label-link" type="condition" conceptid="193322" conceptname="Right lower quadrant pain">lower abdominal pain</span> 3 to 5 weeks after taking My Way, in order to be evaluated for an <span class="product-label-link" type="condition" conceptid="437611" conceptname="Ectopic pregnancy">ectopic pregnancy</span>.</li>
<li>After taking My Way, consider the possibility of pregnancy if your period is delayed more than one week beyond the date you expected your period.</li>
<li>Do not use My Way as routine contraception.</li>
<li>My Way is not effective in terminating an existing pregnancy.</li>
<li>My Way does not protect against HIV-<span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> (AIDS) and other <span class="product-label-link" type="condition" conceptid="440647" conceptname="Sexually transmitted infectious disease">sexually transmitted diseases</span>/<span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>.</li>
<li>For women younger than age 17 years, My Way is available only by prescription.</li>
</ul>
<p class="First">Mfg. by:</p>
<p>Novel laboratories, Inc.<br>Somerset, NJ</p>
<p>Distributed by:</p>
<p>Gavis Pharmaceuticals, LLC</p>
<p>Somerset, NJ</p>
<p>PI 62030002001</p>
<p><span class="Bold">Medication Guide</span></p>
<p>My Way</p>
<p>Emergency Contraceptive</p>
<p>Because the unexpected happens</p>
<p>Important information about My Way,</p>
<p>Birth Control and <span class="product-label-link" type="condition" conceptid="440647" conceptname="Sexually transmitted infectious disease">Sexually Transmitted Diseases</span></p>
<p>For additional information intended for healthcare professionals, please see enclosed Product Information for My Way.</p>
<p><span class="Bold">What is My Way? </span></p>
<p>My Way is emergency contraception that helps prevent pregnancy after birth control failure or unprotected sex. It is a <span class="Bold">backup</span> method of preventing pregnancy and is not to be used routinely.</p>
<p>My Way can reduce your chance of pregnancy after unprotected sex (if your regular birth control was used incorrectly or fails, or if you have had sex without birth control). For example, if you were using a condom and it broke or slipped, if you did not use your regular birth control as you should have, or if you did not use any birth control, My Way may work for you.</p>
<p><span class="Bold">What My Way is not. </span></p>
<p>My Way will not work if you are already pregnant and will not affect an existing pregnancy. My Way should not be used as regular birth control. It is important to have another reliable source of birth control that is right for you. My Way will not protect you from <span class="product-label-link" type="condition" conceptid="439727" conceptname="Human immunodeficiency virus infection">HIV infection</span> (the virus that causes AIDS) and other <span class="product-label-link" type="condition" conceptid="440647" conceptname="Sexually transmitted infectious disease">sexually transmitted diseases</span>.</p>
<p><span class="Bold">When is the appropriate time to use My Way? </span></p>
<p>You can use My Way <span class="Bold">after</span> you have had unprotected sex in the last 72 hours (3 days), and you do not want to become pregnant.</p>
<p>My Way can be used as a backup or emergency method to regular birth control if, for example,</p>
<ul class="Disc">
<li>Your regular birth control method was used incorrectly or failed (your partnerâ€™s condom broke or slipped)</li>
<li>You made a mistake with your regular method</li>
<li>You did not use any birth control method</li>
</ul>
<p><span class="Bold">When is it not appropriate to use My Way?</span></p>
<ul class="Disc">
<li>My Way should not be used as a regular birth control method. It does not work as well as most other forms of birth control when they are used consistently and correctly. My Way is a <span class="Underline">backup or emergency</span> method of contraception.</li>
<li>My Way should not be used if you are already pregnant because it will not work.</li>
<li>My Way should not be used if you are allergic to levonorgestrel or any other ingredients in My Way.</li>
<li>My Way does not protect against HIV (the virus that causes AIDS) or other <span class="product-label-link" type="condition" conceptid="440647" conceptname="Sexually transmitted infectious disease">sexually transmitted diseases</span> (STDs). The best ways to protect yourself against getting HIV or other STDs are to use a latex condom correctly with every sexual act or not to have sex at all.</li>
</ul>
<p><span class="Bold">How does My Way work?</span></p>
<p>My Way is one pill with levonorgestrel, a hormone that has been used in many birth control pills for over 35 years. My Way contains a higher dose of levonorgestrel than birth control pills, but works in a similar way to prevent pregnancy. It works mainly by stopping the release of an egg from the ovary. It is possible that My Way may also work by preventing fertilization of an egg (the uniting of sperm with the egg) or by preventing attachment (implantation) to the uterus (womb).</p>
<p><span class="Bold">How can I get the best results from My Way? </span></p>
<p>You have only a few days to try to prevent pregnancy after unprotected sex. <span class="Bold">The sooner you take My Way, the better it works.</span> My Way should be taken <span class="Bold">as soon as possible within 72 hours (3 days)</span> after unprotected sex.</p>
<p><span class="Bold">How effective is My Way? </span></p>
<p>The sooner you take My Way, the better it will work. Take My Way as soon as possible after unprotected sex. If it is taken as soon as possible within 72 hours (3 days) after unprotected sex, it will significantly decrease the chance that you will get pregnant. Seven out of every 8 women who would have gotten pregnant will not become pregnant.</p>
<p><span class="Bold">How will I know if My Way worked?</span></p>
<p>Most women will have their menstrual period at the expected time or within a week of the expected time. If your menstrual period is delayed beyond 1 week, you may be pregnant. You should get a pregnancy test and follow up with your healthcare professional.</p>
<p><span class="Bold">What if I am already pregnant and use My Way? </span></p>
<p>There is no medical evidence that My Way would harm a developing baby. If you take My Way (accidentally) after you are already pregnant or it does not work and you become pregnant, it is not likely to cause any harm to you or your pregnancy. The pregnancy will continue. My Way will not work if you are already pregnant.</p>
<p><span class="Bold">What should I do if my menstrual period is delayed beyond 1 week and I have severe lower stomach (abdominal) <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>?</span></p>
<p>If you have severe lower stomach (abdominal) <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> about 3 to 5 weeks after taking My Way, you may have a pregnancy outside the uterus, which is called a <span class="product-label-link" type="condition" conceptid="437611" conceptname="Ectopic pregnancy">tubal pregnancy</span>. A <span class="product-label-link" type="condition" conceptid="437611" conceptname="Ectopic pregnancy">tubal pregnancy</span> requires immediate medical treatment, so you should see a healthcare professional right away.</p>
<p><span class="Bold">Can I use My Way for regular birth control? </span></p>
<p>No. My Way should <span class="Underline">not</span> be used for regular birth control. It is an emergency or backup method to be used if your regular birth control fails or is used incorrectly or if you have sex without birth control. You should protect yourself against STDs and pregnancy every time you have sex. If you have unprotected sex again after taking My Way, it will not help protect you from getting pregnant.</p>
<p><span class="Bold">How often can I use My Way? </span></p>
<p>My Way is meant for emergency protection only, and is not designed to be used frequently. If you find that you need to use emergency contraception often, talk to your healthcare professional and learn about methods of birth control and STD prevention that are right for you.</p>
<p><span class="Bold">Will I experience any side effects from My Way? </span></p>
<p>When used as directed, My Way is safe for women. Some women will have mild, temporary side effects, such as menstrual changes, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, lower stomach (abdominal) <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>, <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">tiredness</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="73819" conceptname="Pain of breast">breast pain</span> and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>. These are similar to the side effects that some women have when taking regular birth control pills. Some women taking My Way will have menstrual changes such as spotting or <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> before their next period. Some women may have a heavier or lighter next period, or a period that is early or late. <span class="Bold">If your period is more than a week late, you should get a pregnancy test.</span></p>
<p><span class="Bold">What warnings should I know about when using My Way?</span></p>
<p><span class="Bold">My Way does not protect against AIDS virus (HIV) or other <span class="product-label-link" type="condition" conceptid="440647" conceptname="Sexually transmitted infectious disease">sexually transmitted diseases</span> (STDs).</span></p>
<p><span class="Bold">Do not use: </span></p>
<ul class="Disc">
<li>If you are already pregnant (because it will not work)</li>
<li>If you are allergic to levonogestrel or any of the ingredients in My Way</li>
<li>For regular birth control</li>
</ul>
<p><span class="Bold">When using this product, you may have: </span></p>
<ul class="Disc">
<li>Menstrual changes</li>
<li><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span></li>
<li><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span></li>
<li><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span></li>
<li>Lower stomach (abdominal) <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span></li>
<li><span class="product-label-link" type="condition" conceptid="73819" conceptname="Pain of breast">Breast pain</span></li>
<li><span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">Tiredness</span></li>
<li><span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Vomiting</span></li>
</ul>
<p><span class="Bold">Keep out of reach of children. </span></p>
<p>In case of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, get medical help or contact a Poison Control Center right away at 1-800-222-1222.</p>
<p><span class="Bold">What are the directions for using My Way? </span></p>
<p><span class="Bold">Women 17 years of age and older: </span></p>
<ul class="Disc">
<li>Take My Way as soon as possible within 72 hours (3 days) after unprotected sex.</li>
<li>If you vomit within 2 hours of taking the medication, call a healthcare professional to find out if you should repeat the dose.</li>
<li>Prescription only for women younger than age 17. If you are younger than age 17, see a healthcare professional.</li>
</ul>
<p><span class="Bold">What should I do if I have questions about My Way? </span></p>
<p>If you have questions or need more information about this product, call 1-800-422-8689, visit our website at <a href="http://www.mywaypill.com/">www.mywaypill.com</a>, or ask a healthcare professional.</p>
<p><span class="Bold">Other information </span></p>
<p>Tablet is enclosed in a <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">blister</span> seal. Do not use if the <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">blister</span> seal is broken.</p>
<p>Store at room temperature 20â€“25Â°C (68â€“77Â°F).</p>
<p>You may report side effects to FDA at 1-800-FDA-1088.</p>
<p><span class="Bold">Active ingredient:</span> Levonorgestrel 1.5 mg</p>
<p><span class="Bold">Inactive ingredients:</span> Colloidal silicon dioxide, pregelatinized starch, magnesium stearate, talc, and lactose monohydrate</p>
<p>Protect yourself in more ways than one!</p>
<p>If you are sexually active, but you are not ready for a pregnancy, it is important to use regular pregnancy protection. There are many types of birth control. Whichever type you choose, it is important to use your regular birth control method as directed. This ensures that you have effective protection against pregnancy every time you have sex.</p>
<p>But things do not always go as planned. For example, if you were using a condom and it broke or slipped, or if you did not use your regular birth control as you should have, or if you did not use any birth control, My Way may work for you. My Way is an emergency contraceptive that helps prevent pregnancy after unprotected sex or when your birth control fails or is not used correctly.</p>
<p>Remember, My Way is only for emergency pregnancy prevention. There are many other products that work for regular birth control that are available by prescription or over-the-counter.</p>
<p>There is also another form of protection to think about when you have sex: protection against <span class="product-label-link" type="condition" conceptid="440647" conceptname="Sexually transmitted infectious disease">sexually transmitted diseases</span> (STDs). Some common STDs are HIV/AIDS, Chlamydia, <span class="product-label-link" type="condition" conceptid="200319" conceptname="Herpetic infection of penis">genital herpes</span>, <span class="product-label-link" type="condition" conceptid="433417" conceptname="Gonorrhea">gonorrhea</span>, <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, human <span class="product-label-link" type="condition" conceptid="4034142" conceptname="Papilloma">papilloma</span> virus (HPV), <span class="product-label-link" type="condition" conceptid="198075" conceptname="Condyloma acuminatum">genital warts</span>, <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span>, and trichomonas. Some of these STDs can be very serious and can lead to <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">infertility</span> (inability to have a baby), problems during pregnancy, chronic illness, and even <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>.</p>
<p>All sexually active women are at risk of catching STDs because they may not know that their partner has an STD (the partner himself may not know). <span class="Bold">If your partner uses a latex condom correctly each and every time you have sex with him, this will help reduce, but not eliminate, the chance that you will catch an STD.</span></p>
<p>No other birth control methods will effectively protect you from STDs. The female condom may give you some STD protection, but it is not as effective as a male latex condom.</p>
<p>For more information on STDs, call the Centers for Disease Control and Prevention (CDC) AIDS/STD Hotline. The CDC phone numbers are 1-800-342-AIDS (2437) for English, 1-800-344-7432 for Spanish, or 1-800-243-7889 for <span class="product-label-link" type="condition" conceptid="377889" conceptname="Hearing loss">hearing impaired</span>, TDD.</p>
<p>Be sure to protect yourself against pregnancy and STDs by using some form of birth control plus a latex condom. Of course, not having sex is the most effective way to prevent pregnancy and stay free of STDs</p>
<p>My Way is used to prevent pregnancy after unprotected sex.</p>
<p><span class="Bold">My Way should not be used for regular birth control, if you are already pregnant (because it will not work), or if you are allergic to levonorgestrel or any of the ingredients in My Way.</span></p>
<p><span class="Bold">The sooner you take My Way, the better it will work.</span></p>
<p><span class="Bold">My Way does not protect against the AIDS virus (HIV) or other <span class="product-label-link" type="condition" conceptid="440647" conceptname="Sexually transmitted infectious disease">sexually transmitted diseases</span> (STDs)</span></p>
<p>Common side effects associated with the use of My Way include menstrual changes, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, lower stomach (abdominal) <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>, <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">tiredness</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="73819" conceptname="Pain of breast">breast pain</span> and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-17"></a><p></p>
<h1><span class="Bold">PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
</span></h1>
<p class="First">NDC 43386-620-30</p>
<p>Levonorgestrel Tablet, 1.5 mg</p>
<p>Emergency Contraceptive</p>
<div class="Figure"><img alt="07b96626-figure-02" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c749c15a-2c92-4db9-a6b9-fdf18da5b7da&amp;name=07b96626-figure-02.jpg"></div>
<div class="Figure"><img alt="07b96626-figure-03" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c749c15a-2c92-4db9-a6b9-fdf18da5b7da&amp;name=07b96626-figure-03.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>MY WAYÂ 		
					</strong><br><span class="contentTableReg">levonorgestrel tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:43386-620</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>LEVONORGESTREL</strong> (LEVONORGESTREL) </td>
<td class="formItem">LEVONORGESTREL</td>
<td class="formItem">1.5Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SILICON DIOXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STARCH, CORN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>LACTOSE MONOHYDRATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>TALC</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE (off-white) </td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">8mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:43386-620-30</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA202508</td>
<td class="formItem">02/22/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>GAVIS Pharmaceuticals, LLC.
							(829838551)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant -Â </span>GAVIS Pharmaceuticals, LLC. (829838551)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Novel Laboratories, Inc.</td>
<td class="formItem"></td>
<td class="formItem">793518643</td>
<td class="formItem">ANALYSIS(43386-620), MANUFACTURE(43386-620)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 2/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>07b96626-aa19-4ce3-8ef5-c2cbebdb05f6</div>
<div>Set id: c749c15a-2c92-4db9-a6b9-fdf18da5b7da</div>
<div>Version: 1</div>
<div>Effective Time: 20130227</div>
</div>
</div>Â <div class="DistributorName">GAVIS Pharmaceuticals, LLC.</div></p>
</body></html>
